TNDM

33.11

0.79% 0.26

Handel nachbörslich: 34.00 0.89 +2.69%

Tandem Diabetes Care Inc (TNDM)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TNDM? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$32.85

Offen:

$32.72

24-Stunden-Volumen:

1.02M

Relative Volume:

0.85

Marktkapitalisierung:

$2.20B

Einnahmen:

$796.00M

Nettoeinkommen (Verlust:

$-136.49M

KGV:

-10.25

EPS:

-3.23

Netto-Cashflow:

$-64.24M

1W Leistung:

+0.55%

1M Leistung:

-20.75%

6M Leistung:

-25.96%

1J Leistung:

+110.22%

1-Tages-Spanne:

$32.66

$33.88

1-Wochen-Bereich:

$31.10

$33.88

52-Wochen-Spanne:

$13.82

$53.69

Tandem Diabetes Care Inc Stock (TNDM) Company Profile

Firmenname

Tandem Diabetes Care Inc

Sektor

Healthcare (1182)

Branche

Medical Devices (148)

Telefon

858-366-6900

Adresse

12400 HIGH BLUFF DRIVE, San Diego, CA

Mitarbeiter

2,400

Twitter

@tandemdiabetes

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

TNDM's Discussions on Twitter

Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-08-04	Herabstufung	Citigroup	Buy → Neutral
2023-05-05	Herabstufung	BofA Securities	Neutral → Underperform
2023-04-24	Herabstufung	Raymond James	Outperform → Mkt Perform
2023-03-29	Eingeleitet	UBS	Neutral
2023-01-26	Eingeleitet	Wolfe Research	Peer Perform
2022-11-15	Hochstufung	Wells Fargo	Underweight → Equal Weight
2022-10-18	Eingeleitet	Barclays	Overweight
2022-10-12	Eingeleitet	Jefferies	Buy
2022-08-09	Herabstufung	Wells Fargo	Overweight → Underweight
2022-03-02	Fortgesetzt	BofA Securities	Neutral
2022-01-19	Hochstufung	Wells Fargo	Equal Weight → Overweight
2021-07-21	Fortgesetzt	Cowen	Outperform
2021-05-25	Eingeleitet	Barclays	Underweight
2020-12-15	Herabstufung	Wells Fargo	Overweight → Equal Weight
2020-08-20	Eingeleitet	Wells Fargo	Overweight
2020-07-31	Hochstufung	Guggenheim	Neutral → Buy
2020-07-06	Hochstufung	Citigroup	Neutral → Buy
2020-06-18	Bestätigt	Raymond James	Outperform
2020-04-24	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2020-03-23	Herabstufung	Guggenheim	Buy → Neutral
2020-03-05	Eingeleitet	Citigroup	Neutral
2020-02-06	Eingeleitet	Raymond James	Outperform
2020-02-04	Herabstufung	Robert W. Baird	Outperform → Neutral
2019-10-18	Eingeleitet	Guggenheim	Buy
2019-10-04	Hochstufung	UBS	Neutral → Buy
2019-05-17	Bestätigt	BofA/Merrill	Neutral
2019-05-13	Eingeleitet	SVB Leerink	Outperform
2019-03-08	Eingeleitet	BMO Capital Markets	Outperform
2019-03-05	Bestätigt	BofA/Merrill	Neutral
2019-02-27	Bestätigt	Lake Street	Buy
2018-11-21	Hochstufung	Robert W. Baird	Neutral → Outperform
2018-09-26	Bestätigt	Dougherty & Company	Buy
2018-09-26	Bestätigt	Piper Jaffray	Overweight

Alle ansehen

Tandem Diabetes Care Inc Aktie (TNDM) Neueste Nachrichten

Nov 03, 2024

Analysts Estimate Tandem Diabetes Care, Inc. (TNDM) to Report a Decline in Earnings: What to Look Out for - MSN

Nov 03, 2024

abrdn plc Makes New Investment in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat

Nov 03, 2024

Nov 01, 2024

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Bought by Stephens Investment Management Group LLC - MarketBeat

Nov 01, 2024

Oct 31, 2024

Mirae Asset Global Investments Co. Ltd. Boosts Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat

Oct 31, 2024

Tandem Diabetes Care Announces Upcoming Conference Participation - BioSpace

Oct 31, 2024

Oct 30, 2024

Tandem Diabetes Care (TNDM) Set to Announce Earnings on Wednesday - MarketBeat

Oct 30, 2024

Oct 27, 2024

Assenagon Asset Management S.A. Acquires 66,138 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat

Oct 27, 2024

Oct 25, 2024

Apple Tests Blood-Sugar App in Sign of Its Health Ambitions - BNN Bloomberg

Oct 25, 2024

Recent 8.8% pullback isn't enough to hurt long-term Tandem Diabetes Care (NASDAQ:TNDM) shareholders, they're still up 77% over 1 year - Simply Wall St

Oct 25, 2024

Oct 24, 2024

(TNDM) Trading Signals - Stock Traders Daily

Oct 24, 2024

Tandem Diabetes Care's SWOT analysis: insulin pump maker faces growth hurdles - Investing.com India

Oct 24, 2024

Tandem Diabetes Care's SWOT analysis: insulin pump maker faces growth hurdles By Investing.com - Investing.com South Africa

Oct 24, 2024

Further weakness as Tandem Diabetes Care (NASDAQ:TNDM) drops 14% this week, taking three-year losses to 75% - Yahoo Finance

Oct 24, 2024

Oct 21, 2024

Down -21.69% in 4 Weeks, Here's Why Tandem Diabetes Care (TNDM) Looks Ripe for a Turnaround - MSN

Oct 21, 2024